Mandy Xie

Mandy Xie is an accomplished executive with extensive experience in cell therapy and biologics development. Currently serving as the Executive Director of Cell Therapy Product & Analytical Development at Bristol Myers Squibb since October 2019, Mandy leads the analytical R&D function and oversees various critical areas including control strategy, assay development, and clinical QC. Previously, as Senior Director in Cell Therapy Late Stage CMC Portfolio and Business Development, Mandy spearheaded global filing and approval processes for cell therapy products. Prior to joining Bristol Myers Squibb, Mandy held notable positions at GSK, MedImmune, Pfizer, Baxter International Inc., and began a career at the National Standardization Research Institute. Mandy earned a PhD in Analytical Chemistry from The University of Georgia.